巨細胞動脈炎：治療薬のグローバル治験動向（2014年下半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Giant Cell Arteritis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Giant Cell Arteritis 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Giant Cell Arteritis Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
F. Hoffmann-La Roche Ltd. 28
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 28
Laboratorios Servier, S.L. 29
Clinical Trial Overview of Laboratorios Servier, S.L. 29
Janssen Global Services, LLC 30
Clinical Trial Overview of Janssen Global Services, LLC 30
Clinical Trial Overview of Top Institutes / Government 31
University of Oxford 31
Clinical Trial Overview of University of Oxford 31
Centre Hospitalier Universitaire Dijon 32
Clinical Trial Overview of Centre Hospitalier Universitaire Dijon 32
Japan Intractable Diseases Research Foundation 33
Clinical Trial Overview of Japan Intractable Diseases Research Foundation 33
FDA Office of Orphan Products Development 34
Clinical Trial Overview of FDA Office of Orphan Products Development 34
Saitama Medical University 35
Clinical Trial Overview of Saitama Medical University 35
University of Bern 36
Clinical Trial Overview of University of Bern 36
Caen University Hospital 37
Clinical Trial Overview of Caen University Hospital 37
University Hospital, Toulouse 38
Clinical Trial Overview of University Hospital, Toulouse 38
University of Pennsylvania 39
Clinical Trial Overview of University of Pennsylvania 39
National Institute of Arthritis and Musculoskeletal and Skin Diseases 40
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 40
Five Key Clinical Profiles 41
Appendix 68
Abbreviations 68
Definitions 68
Research Methodology 69
Secondary Research 69
About GlobalData 70
Contact Us 70
Disclaimer 70
Source 70